Study aims to improve shared Decision-Making in metastatic breast cancer

NCT ID NCT03248258

Completed Knowledge-focused Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study from the University of Alabama at Birmingham involved 200 women with metastatic or early-stage breast cancer. Researchers conducted interviews and focus groups with patients, nurses, and doctors to understand how treatment decisions are made, including the option to reduce chemotherapy. The goal was to develop an electronic treatment plan that supports shared decision-making, where patients' values and preferences are considered alongside medical advice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better communication tools that help patients and doctors make treatment choices together, improving quality of care.
What could go wrong: This is a small, qualitative study that does not test a treatment. The findings may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DE-ESCALATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DE-ESCALATION DECISION MAKING ,SHARED

Contacts and locations

Locations

University of Alabama at Birmingham

Birmingham, Alabama, 35249, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.